U.S. hands Novavax $1.6b to work on COVID-19 vaccine
Video Credit: Reuters Studio - Duration: 02:12s - Published
U.S. hands Novavax $1.6b to work on COVID-19 vaccine
The U.S. government awarded $1.6 billion to help Novavax quickly come up with a potential novel coronavirus vaccine, sending the stock surging more than 30 percent.
Conway G.
Gittens has more.